Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 507, Issue 1-2, Pages 72-82Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2016.05.005
Keywords
Polymeric nanoparticles; Skin disease; Chitosan; Topical glucocorticoids; Antimicrobial activity; Dermal pharmacokinetics; Safety
Categories
Funding
- Universiti Kebangsaan Malaysia [UKM-AP-2013-002]
Ask authors/readers for more resources
The objective of this study was to investigate the in-vivo behavior of topically applied cationic polymeric chitosan nanoparticles (CSNPs) loaded with anti-inflammatory (hydrocortisone, HC) and antimicrobial (hydroxytyrosol, HT) drugs, to elucidate their skin targeting potential for the treatment of atopic dermatitis (AD). Compared to the commercial formulation, the HC-HT loaded CSNPs showed significantly improved drug penetration into the epidermal and dermal layers of albino Wistar rat skin without saturation. Dermal pharmacokinetic of CSNPs with a size of 228.5 +/- 7 nm and +39 +/- 5 mV charges revealed that they penetrated 2.46-fold deeper than the commercial formulation did, and had greater affinity at the skin target site without spreading to the surrounding tissues, thereby providing substantial safety benefits. In repeated dermal application toxicity studies, the HC-HT CSNPs showed no evidence of toxicity compared to the commercial formulation, which induced skin atrophy and higher liver enzyme levels. In conclusion, the positively charged HC-HT CSNP formulation exhibited promising local delivery and virtually no treatment-related toxicities, suggesting it may be an efficient and viable alternative for commercially available AD treatments. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available